Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 6, 2014, Pages 1287-1299

  Pondman, Kirsten M ^a,b,c   Sobik, Martin ^a   Nayak, Annapurna ^c   Tsolaki, Anthony G ^c   Jäkel, Anne ^b   Flahaut, Emmanuel ^d   Hampel, Silke ^e   ten Haken, Bennie ^a   Sim, Robert B ^b,f   Kishore, Uday ^c  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d INSTITUT CARNOT CIRIMAT   (France)

^e IFW DRESDEN   (Germany)

^f KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

C1q; Carbon nanotubes; Complement; Cytokines; Macrophage

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CARBON NANOTUBES; IMMUNE SYSTEM; MACROPHAGES;

ANTI-INFLAMMATORIES; C1Q; CELLULAR INFILTRATION; COMPLEMENT; COMPLEMENT ACTIVATIONS; CYTOKINES; INNATE IMMUNE SYSTEMS; PRO-INFLAMMATORY CYTOKINES;

CHEMICAL ACTIVATION;

CARBON NANOTUBE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CYTOKINE RESPONSE; DOWN REGULATION; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MONOCYTE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; U937 CELL LINE; UPREGULATION; CELL LINE; DRUG EFFECTS; IMMUNOLOGY; ULTRASTRUCTURE;

CELL LINE; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; CYTOKINES; HUMANS; MACROPHAGES; NANOTUBES, CARBON; PHAGOCYTOSIS;

EID: 84905273117     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.02.010     Document Type: Article

References (52)

1. Bianco A., Kostarelos K., Partidos C.D., Prato M. Biomedical applications of functionalized carbon nanotubes. Chem Commun 2005, 5:571-577.
2. Sinha N., Yeow J.T. Carbon nanotubes for biomedical applications. IEEE Trans Nanobioscience 2005, 4:180-195.
3. Klingeler R., Hampel S., Buchner B. Carbon nanotube based biomedical agents for heating, temperature sensoring and drug delivery. Int J Hyperthermia 2008, 24:496-505.
4. Bianco A., Kostarelos K., Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005, 9:674-679.
5. Biale C., Mussi V., Valbusa U., et al. Carbon nanotubes for targeted drug delivery. 2009 9th IEEE Conf Nanotechnol (Ieee-Nano) 2009, 644-646.
6. Ali-Boucetta H., Al-Jamal K.T., McCarthy D., Prato M., Bianco A., Kostarelos K. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem Commun (Camb) 2008, 4:459-461.
7. Heister E., Neves V., Tîlmaciu C., et al. Triple functionalization of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy. Carbon 2009, 47:2152-2160.
8. Wu W., Wieckowski S., Pastorin G., et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed 2005, 44:6358-6362.
9. Foldvari M., Bagonluri M. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine 2008, 4:183-200.
10. Foldvari M., Bagonluri M. Carbon nanotubes as functional excipients for nanomedicines: I. Pharm Properties Nanomedicine 2008, 4:173-182.
11. Lacerda L., Bianco A., Prato M., Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev 2006, 58:1460-1470.
12. Taylor A., Kraemer K., Hampel S., et al. Carbon coated nanomagnets as potential hyperthermia agents. J Urol 2008, 179:392-393.
13. Krupskaya Y., Mahn C., Parameswaran A., et al. Magnetic study of iron-containing carbon nanotubes: feasibility for magnetic hyperthermia. J Magn Magn Mater 2009, 321:4067-4071.
14. Bhattacharya K., Andon F.T., El-Sayed R., Fadeel B. Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation. Adv Drug Deliv Rev 2013, 65:2087-2097.
15. Basiuk V.A., Salvador-Morales C., Basiuk E.V., et al. 'Green' derivatization of carbon nanotubes with Nylon 6 and l-alanine. J Mater Chem 2006, 16:4420-4426.
16. Dumortier H., Lacotte S., Pastorin G., et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Letters 2006, 6:3003.
17. Zolnik B.S., Gonzalez-Fernandez A., Sadrieh N., Dobrovolskaia M.A. Minireview: nanoparticles and the immune system. Endocrinology 2010, 151:458-465.
18. Salvador-Morales C., Basiuk E.V., Basiuk V.A., Green M.L.H., Sim R.B. Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. J Nanosci Nanotechnol 2008, 8:2347-2356.
19. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L.H., Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 2006, 43:193-201.
20. Rybak-Smith M.J., Pondman K.M., Flahaut E., Salvador-Morales C., Sim R.B. Recognition of carbon nanotubes by the human innate immune system. Carbon nanotubes for biomedical applications 2011, 183-210. Springer. R.S. Klingeler, B. Robert (Eds.).
21. Salvador-Morales C., Green M.L.H., Sim R.B. Interaction between carbon nanotubes and biomolecules. Chemistry of carbon nanotubes 2007, American Scientific Publishers. E.V. Basiuk, V.A. Basiuk (Eds.).
22. Carroll M.V., Sim R.B. Complement in health and disease. Adv Drug Deliv Rev 2011, 63:965-975.
23. Kang Y.H., Tan L.A., Carroll M.V., Gentle M.E., Sim R.B. Target pattern recognition by complement proteins of the classical and alternative pathways. Adv Exp Med Biol 2009, 653:117-128.
24. Ikeda K., Sannoh T., Kawasaki N., Kawasaki T., Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987, 262:7451-7454.
25. Bhakdi S., Tranum-Jensen J. Complement lysis: a hole is a hole. Immunol Today 1991, 12:318-320. [discussion 21].
26. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998, 16:545-568.
27. Hamad I., Hunter A.C., Rutt K.J., Liu Z., Dai H., Moghimi S.M. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol Immunol 2008, 45:3797-3803.
28. Andersen A.J., Robinson J.T., Dai H.J., Hunter A.C., Andresen T.L., Moghimi S.M. Single-walled carbon nanotube surface control of complement recognition and activation. Acs Nano 2013, 7:1108-1119.
29. Ling W.L., Biro A., Bally I., et al. Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. Acs Nano 2011, 5:730-737.
30. Flahaut E., Bacsa R., Peigney A., Laurent C. Gram-scale CCVD synthesis of double-walled carbon nanotubes. Chem Commun 2003, 12:1442-1443.
31. Muller C., Hampel S., Elefant D., et al. Iron filled carbon nanotubes grown on substrates with thin metal layers and their magnetic properties. Carbon 2006, 44:1746-1753.
32. Lipert K., Kretzschmar F., Ritschel M., Leonhardt A., Klingeler R., Buchner B. Nonmagnetic carbon nanotubes. J Appl Phys 2009, 105.
33. Jeynes J.C.G., Mendoza E., Chow D.C.S., Watts P.C.R., McFadden J., Silva S.R.P. Generation of chemically unmodified pure single-walled carbon nanotubes by solubilizing with RNA and treatment with ribonuclease A. Adv Mater 2006, 18:1598-1602.
34. Tan L.A., Yu B., Sim F.C., Kishore U., Sim R.B. Complement activation by phospholipids: the interplay of factor H and C1q. Protein Cell 2010, 1:1033-1049.
35. Kishore U., Gupta S.K., Perdikoulis M.V., Kojouharova M.S., Urban B.C., Reid K.B.M. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J Immunol 2003, 171:812-820.
36. Yang M., Flavin K., Kopf I., et al. Functionalization of carbon nanoparticles modulates inflammatory cell recruitment and NLRP3 inflammasome activation. Small 2013, 9:4194-4206.
37. Roumenina L., Bureeva S., Kantardjiev A., et al. Complement C1q-target proteins recognition is inhibited by electric moment effectors. J Mol Recognit 2007, 20:405-415.
38. Ghai R., Waters P., Roumenina L.T., et al. C1q and its growing family. Immunobiology 2007, 212:253-266.
39. Kishore U., Gaboriaud C., Waters P., et al. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 2004, 25:551-561.
40. Dodds A.W., Porter R.R. Activation of complement components by aggregates of antibodies and their fragments. Mol Immunol 1979, 16:1059-1062.
41. Szebeni J., Bedocs P., Csukas D., Rosivall L., Bunger R., Urbanics R. A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines. Adv Drug Deliver Rev 2012, 64:1706-1716.
42. Vogt W., von Zabern I., Damerau B., Hesse D., Luhmann B., Nolte R. Mechanisms of complement activation by crystalline cholesterol. Mol Immunol 1985, 22:101-106.
43. Dutta D., Sundaram S.K., Teeguarden J.G., et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 2007, 100:303-315.
44. Kang B., Yu D.C., Chang S.Q., Chen D., Dai Y.D., Ding Y. Intracellular uptake, trafficking and subcellular distribution of folate conjugated single walled carbon nanotubes within living cells. Nanotechnology 2008, 19:375103.
45. Kostarelos K., Lacerda L., Pastorin G., et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol 2007, 2:108-113.
46. Pantarotto D., Briand J.P., Prato M., Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb) 2004, 1:16-17.
47. Mu Q.X., Broughton D.L., Yan B. Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. Nano Lett 2009, 9:4370-4375.
48. Jin H., Heller D.A., Strano M.S. Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Lett 2008, 8:1577-1585.
49. Murphy F.A., Schinwald A., Poland C.A., Donaldson K. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part Fibre Toxicol 2012, 9:8.
50. Andersen A.J., Wibroe P.P., Moghimi S.M. Perspectives on carbon nanotube-mediated adverse immune effects. Adv Drug Deliver Rev 2012, 64:1700-1705.
51. Shvedova A.A., Kisin E., Murray A.R., et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol-Lung C 2008, 295:L552-L565.
52. Meunier E., Coste A., Olagnier D., et al. Double-walled carbon nanotubes trigger IL-1 beta release in human monocytes through Nlrp3 inflammasome activation. Nanomed Nanotechnol 2012, 8:987-995.